Development and evaluation of novel lipid-polymer hybrid nanocarrier system for targeted delivery of HPPH and olaparib for effective triple negative breast cancer treatment
JavaScript is disabled for your browser. Some features of this site may not work without it.
Development and evaluation of novel lipid-polymer hybrid nanocarrier system for targeted delivery of HPPH and olaparib for effective triple negative breast cancer treatment